Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil

PURPOSE: The systemic treatment options for metastatic colorectal cancer (mCRC) are unsatisfactory, and the disease recurs despite the use of numerous medications and their combinations. Trifluridine/Tipiracil is a relatively new drug used in refractory mCRC. Little is known about its real-world eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Koper, Agnieszka, Wileński, Sławomir, Śledzińska, Paulina, Bebyn, Marek, Koper, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423107/
https://www.ncbi.nlm.nih.gov/pubmed/37318592
http://dx.doi.org/10.1007/s00432-023-04909-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423107/
https://www.ncbi.nlm.nih.gov/pubmed/37318592
http://dx.doi.org/10.1007/s00432-023-04909-6

Ejemplares similares